Xiaobo X. Cao

发表

Receptor tyrosine kinase and phosphoinositide-3 kinase signaling in malignant mesothelioma.

P. Rascoe, Xiaobo X. Cao, Jonathan C. Daniel, 2005, The Journal of thoracic and cardiovascular surgery.

Bcl‐xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts

Lidong Zhang, Xiaobo X. Cao, Steven D. Miller, 2008, International journal of cancer.

Molecular Pathogenesis of Malignant Pleural Mesothelioma

P. Rascoe, Xiaobo X. Cao, W. Smythe, 2012 .

Bcl2/bcl-xl inhibitor engenders apoptosis and increases chemo-sensitivity in mesothelioma

Lidong Zhang, Xiaobo X. Cao, W. Smythe, 2007, Cancer biology & therapy.

The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition

J. Yap, S. Fletcher, P. Rascoe, 2012, BMC Cancer.

Adenoviral Transfer of mda-7 Leads to BAX Up-regulation and Apoptosis in Mesothelioma Cells, and is Abrogated by Over-expression of BCL-XL

D. McConkey, A. Mhashilkar, S. Chada, 2002, Molecular medicine.

Apoptotic signaling induces hyperpermeability following hemorrhagic shock.

J. Tinsley, B. Tharakan, Xiaobo X. Cao, 2007, American journal of physiology. Heart and circulatory physiology.

Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma.

W. Hong, Xiaobo X. Cao, Steven D. Miller, 2004, Molecular cancer therapeutics.

Gene therapy for sarcoma utilizing adenoviral transfer of the beta-glucuronidase and bax genes and an anthracyline prodrug.

Imran T. Mohiuddin, Xiaobo X. Cao, Jonathan C. Daniel, 2004, The Journal of surgical research.

Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product.

Xiaobo X. Cao, W. Smythe, I. Mohuiddin, 2002, Journal of Thoracic and Cardiovascular Surgery.

Research of bortezomib-adapted I-45 mesothelioma cells

Lidong Zhang, Xiaobo X. Cao, W. Smythe, 2010 .

Open Access Research Characterization of Bortezomib-adapted I-45 Mesothelioma Cells

Lidong Zhang, Xiaobo X. Cao, W. Smythe, 2022 .

Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells

Wei Guo, B. Fang, Lidong Zhang, 2005, Molecular Cancer Therapeutics.

Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma

Imran T. Mohiuddin, B. Fang, Xiaobo X. Cao, 2001, Cancer Gene Therapy.

Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells

J. Minna, J. Roth, S. Swisher, 2015, Oncotarget.

Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors.

Alexander D. MacKerell, P. Wilder, J. Yap, 2012, Organic & biomolecular chemistry.

TUSC2 Immunogene Therapy Synergizes with Anti–PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models

Jing Wang, J. Roth, V. Baladandayuthapani, 2018, Cancer Immunology Research.

Molecular pathogenesis of malignant mesothelioma

Xiaobo Cao, Daniel Jupiter, P. Rascoe, 2012, Expert Reviews in Molecular Medicine.

Enhancing TRAIL-induced apoptosis by Bcl-XL siRNA

Xiaobo Cao, Hongbo Zhu, B. Fang, 2005, Cancer biology & therapy.

The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein–protein interactions with Bak

Alexander D. MacKerell, Xiaobo Cao, Kenno Vanommeslaeghe, 2013, Molecular Cancer.

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)

Jing Wang, J. Roth, B. Dai, 2017, Oncotarget.

Total laparoscopic versus laparoscopic-assisted transabdominal posterior mediastinal digestive tract reconstruction in the treatment of Siewert II adenocarcinoma of the esophagogastric junction: A retrospective study

Xiaobo X. Cao, Jiajia Wei, Su Yan, 2022, Frontiers in Surgery.

Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics

J. Roth, V. Baladandayuthapani, L. Ji, 2017, Oncotarget.

Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors.

K. Hamid, Lidong Zhang, P. Rascoe, 2009, The American journal of pathology.

Internalization of exogenous ADP-ribosylation factor 6 (Arf6) proteins into cells

Xiaobo X. Cao, M. Uddin, A. Asea, 2011, Molecular and Cellular Biochemistry.

Alexander D. MacKerell, P. Wilder, J. Yap, 2013, Molecular Cancer.

TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin

Jing Wang, J. Roth, V. Baladandayuthapani, 2016, Scientific Reports.

Molecular pathogenesis of malignant mesothelioma

P. Rascoe, Xiaobo X. Cao, W. Smythe, 2012, Expert Reviews in Molecular Medicine.

Sodium butyrate markedly augments pro-apoptotic gene therapy via alterations in bcl-2 family protein expression

Imran T. Mohiuddin, Xiaobo X. Cao, W. Smythe, 2000 .